Glenmark Pharmaceuticals
GLENMARK.NS
#2587
Rank
S$7.41 B
Marketcap
$26.27
Share price
0.21%
Change (1 day)
106.65%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand

Cash on Hand as of March 2024 : S$0.29 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company has S$0.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31S$0.23 B-8.06%
2022-03-31S$0.25 B15.58%
2021-03-31S$0.22 B-0.02%
2020-03-31S$0.22 B0.74%
2019-03-31S$0.22 B-22.2%
2018-03-31S$0.28 B8.55%
2017-03-31S$0.26 B50.08%
2016-03-31S$0.17 B2.36%
2015-03-31S$0.17 B0.05%
2014-03-31S$0.17 B21.3%
2013-03-31S$0.14 B71.69%
2012-03-31S$81.8 M48.51%
2011-03-31S$55.08 M64.8%
2010-03-31S$33.42 M56.07%
2009-03-31S$21.41 M-60.39%
2008-03-31S$54.07 M45.5%
2007-03-31S$37.16 M-3.01%
2006-03-31S$38.31 M-20.44%
2005-03-31S$48.15 M1434.05%
2004-03-31S$3.13 M